Shire plc (SHPG) EPS & PE Ratio History
Current and historical earning per share (EPS) and price to earnings (PE) ratio for Shire plc (SHPG) over the last 10 years. The current PE ratio for Shire plc as of February 20, 2018 is 8.36.
|Medical||Medical - Drug Manufacturing||$38.114B||$15.161B|
|Shire Pharmaceuticals Group plc is a specialty pharmaceutical company focused primarily on two therapeutic areas: central nervous system disorders and metabolic bone diseases. (press release)|